Niclosamide, an oral antihelmintic drug, exhibits antimetastatic activity in hepatocellular carcinoma cells through downregulating twistâmediated CD10 expression
Sign Up to like & getrecommendations! Published in 2018 at "Environmental Toxicology"
DOI: 10.1002/tox.22551
Abstract: Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world, especially, in eastern Asia, and its prognosis is poor once metastasis occurs. Niclosamide, a US Food and Drug Administrationâapproved antihelmintic drug, was… read more here.
Keywords: hepatocellular carcinoma; antihelmintic drug; hcc; cd10 expression ... See more keywords
Stromal CD10 expression in gastric adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medicine and Life"
DOI: 10.25122/jml-2021-0244
Abstract: Gastric adenocarcinoma is a malignant neoplasm of the gastric mucosa composed of neoplastic cells and supporting stroma as with any neoplasm. Stromal myofibroblasts have an essential role in creating the tumor-promoting environment. They express certain… read more here.
Keywords: gastric adenocarcinoma; cd10 expression; stromal cd10;
Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy
Sign Up to like & getrecommendations! Published in 2023 at "Pathology and Oncology Research"
DOI: 10.3389/pore.2022.1610598
Abstract: Background: The therapeutic strategy of invasive breast cancer is based on routine histopathological markers (estrogen-, progesterone receptor, HER2, Ki67) routinely evaluated in tumor cells. However, the assessment of cancer stroma could influence therapeutic strategies. Studies… read more here.
Keywords: breast cancer; cd10 expression; expression;